Market Research Reports and Industry Reports

Italy Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

This new report from VPGMarketResearch.com is based on a study of the major business opportunities emerging in the Italian cancer diagnostics market during the next five years. The report examines trends in the Italian market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Italian cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

Italian Market Overview

- Five-year test volume and sales projections. - Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers. - Estimated universe of laboratories performing cancer diagnostic testing. - Cancer statistics, etiology and recent developments in Italy.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Test

- Oncogenes - Biochemical Markers - Growth Factors - Colony Stimulating Factors - Hormones - Immunohistochemical Stains - Lymphokines

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major cancer diagnostic product suppliers by individual test.

- Five-year test volume and sales forecasts for major tumor markers by market segment, including:

     º  Hospitals      º  Commercial/Private Laboratories

Instrumentation Review

- Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment

- Assessment of latest technologies and their potential applications for cancer diagnostic testing. - Review of competing/complementing technologies. - Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott    - AdnaGen    - Agilent Technologies    - Applied Gene Technologies    - Arca Biopharma    - Beckman Coulter/Danaher    - Becton Dickinson    - Biomedical Diagnostics    - bioMerieux    - Bio-Rad    - CellSearch    - Cepheid    - Correlogic Systems/Vermillion    - Decode Genetics    - Diadexus    - Diagnocure    - DiaSorin    - Eiken Chemical    - Elitech Group    - Enterix    - Enzo Biochem    - Epigenomics    - Exact Sciences    - Fujirebio    - Guided Therapeutics    - Hologic/Gen-Probe    - Kreatech/Leica    - Kyowa Medex    - Mackay Life Sciences    - Myriad Genetics    - OncoLab    - Ortho-Clinical Diagnostics    - Panacea Pharmaceuticals    - Polartechnics    - Polymedco    - PreMD    - Qiagen    - Quest Diagnostics    - Radient Pharmaceuticals    - Roche    - Scienion    - Sequenom    - Siemens Healthcare    - Takara Bio    - Targeted Diagnostics & Therapeutics    - Thermo Fisher    - Tosoh    - Veridex    - Wako Pure Chemicals    - Wallac/PE    - Zilla

 I. Introduction

II. Worldwide Market Overview

A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth

III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

VI. Potential Market Entry Barriers and Risks

VII. Worldwide Market and Technology Overview

A. Major Current and Emerging Cancer Diagnostic Tests
1. Biochemical Tumor Markers
2. Oncogenes
3. Polypeptide Growth Factors
4. Ectopic Hormones
5. Colony Stimulating Factors
6. Lymphokines
7. Immunohistochemical Stains
8. Emerging Tumor Markers
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies
D. Personal Testing

VIII. Italy
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares

IX. Competitive Profiles
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca
   Biop
   harma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode
Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
Table of Contents
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech
/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical
  Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen/Ipsogen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila

X.Appendix:
 
Major Universities and Research
Centers Developing Cancer Diagnostic
Technologies and Applications


List Of Tables

Cancer Diagnostic Classification

Major Companies Developing or Marketing

ACTH Tests

Major Companies Developing or Marketing

AFP Tests

Major Companies Developing or Marketing

Beta-2 Microglobulin Tests

Major Companies Developing or Marketing

CA 15-3/27.29 Tests

Major Companies Developing or Marketing

CA 19-9 Tests

Major Companies Developing or Marketing

CA 125 Tests

Major Companies Developing or Marketing

Calcitonin Test

Major Companies Developing or Marketing

CEA Tests

Major Companies Developing or Marketing

Estrogen Receptor Tests

Major Companies Developing or Marketing

Progesterone Receptor Tests

Major Companies Developing or Marketing

Ferritin Tests

Major Companies Developing or Marketing

Gastrin Tests

Major Companies Developing or Marketing

HCG Tests

Major Companies Developing or Marketing

Insulin Tests

Major Companies Developing or Marketing

NSE Tests

Major Companies Developing or Marketing

Occult Blood Tests

Major Companies Developing or Marketing

PAP Smear/HPV Tests

Major Companies Developing or Marketing

PAP Tests

Major Companies Developing or Marketing

PSA Tests

Major Companies Developing or Marketing

Lymphocyte Subclassification Tests

Biochemical Markers Potential Applications

In Cancer Diagnosis

Oncogenes Potential Applications

In Cancer Diagnosis

Major Companies Developing or Marketing

Oncogene Tests

Growth Factors Potential Applications

In Cancer Diagnosis

Colony Stimulating Factors Potential

Applications in Cancer Diagnosis

Lymphokines Potential Applications In Cancer Diagnosis

Immunohistochemical Stains Potential

Applications in Cancer Diagnosis

Executive Summary Table: Italy, Total Cancer

Diagnostic Testing Volume and Diagnostics Sales

Forecasts by Market Segment

Italy, Estimated Cancer Death Rates

Italy, Laboratories Performing Cancer

Diagnostic Tests by Market Segment

Italy, Hospital Laboratories Performing

Cancer Diagnostic Tests by Bed Size

Italy, Commercial/Private Laboratories

Performing Cancer Diagnostics Tests

By Annual Test Volume

Italy, Total Cancer Diagnostic Test Volume

Forecasts by Market Segment

Italy, All Market Segments Major Cancer

Diagnostic Test Volume Forecasts by Test

Italy, Hospital Laboratories Major Cancer

Diagnostic Test Volume Forecasts

Italy, Commercial/Private Laboratories

Major Cancer Diagnostic Test Volume Forecasts

Italy, Total Cancer Diagnostic Test Market

Forecasts by Market Segment

Italy, All Market Segments Major Cancer

Diagnostic Sales Forecasts by Test

Italy, Hospital Laboratories Major

Cancer Diagnostic Forecasts by Test

Italy, Commercial/Private Laboratories

Major Cancer Diagnostic Sales Forecasts by Test

Italy, ACTH Test Volume and Diagnostics

Sales Forecasts by Market Segment

Italy, AFP Test Volume and Diagnostics

Sales Forecasts by Market Segment

Italy, Beta-2 Microglobulin Test Volume

And Diagnostics Sales Forecasts by Market Segment

Italy, CA 15-3/27.29 Test Volume and

Diagnostics Sales Forecasts by Market Segment

Italy, CA-19-9 Test Volume and Diagnostics

Sales Forecasts by Market Segment

Italy, CA 125 Test Volume and Diagnostics

Sales Forecasts by Market Segment

Italy, Calcitonin Test Volume and Diagnostics

Sales Forecasts by Market Segment

Italy, CEA Test Volume and Diagnostics Sales

Forecasts by Market Segment

Italy, Chromogranin Test Volume

And Diagnostics Sales Forecasts by Market Segment

Italy, Colon Specific Antigen Test Volume

And Diagnostics Sales Forecasts by Market Segment

Italy, Cytokeratins Test Volume and

Diagnostics Sales Forecasts by Market Segment

Italy, Estrogen Receptor Test Volume and

Diagnostics Sales Forecasts by Market Segment

Italy, Ferritin Test Volume and Diagnostics

Sales Forecasts by Market Segment

Italy, Gastrin Test Volume and Diagnostics

Sales Forecasts by Market Segment

Italy, HCG Test Volume and Diagnostics

Sales Forecasts by Market Segment

Italy, Insulin Test Volume and Diagnostics

Sales Forecasts by Market Segment

Italy, Lymphocyte Subtyping Test Volume

And Diagnostics Sales Forecasts by Market

Segment

Italy, NSE Test Volume and Diagnostics Sales

Forecasts by Market Segment

Italy, Occult Blood Test Volume and Diagnostics

Sales Forecasts by Market Segment

Italy, Oncogenes Test Volume and Diagnostics

Sales Forecasts by Market Segment

Italy, Pancreatic Oncofetal Antigen Test

Volume and Diagnostics Sales Forecasts

By Market Segment

Italy, PAP Smear Test Volume and

Diagnostics Sales Forecasts by Market Segment

Italy, Parathyroid Hormone Test Volume and

Diagnostics Sales Forecasts by Market Segment

Italy, Progesterone Receptor Test Volume and

Diagnostics Sales Forecasts by Market Segment

Italy, PAP Test Volume and Diagnostics Sales

Forecasts by Market Segment

Italy, PSA Test Volume and Diagnostics Sales

Forecasts by Market Segment

Italy, S-100 Test Volume and Diagnostics

Sales Forecasts by Market Segment

Italy, Serotonin Test Volume and

Diagnostics Sales Forecasts by Market Segment

Italy, Sialic Acid Test Volume and

Diagnostics Sales Forecasts by Market Segment

Italy, Squamous Cell Carcinoma Antigen Test

Volume and Diagnostics Sales Forecasts

By Market Segment

Italy, TDT Test Volume and Diagnostics Sales

Forecasts by Market Segment

Italy, Thymidine Kinase Test Volume and

Diagnostics Sales Forecasts by Market Segment

Italy, Thyroglobulin Test Volume and

Diagnostics Sales Forecasts by Market Segment

Italy, TPA Test Volume and Diagnostics Sales

Forecasts by Market Segment

Italy, Total Cancer Diagnostics

Sales by Major Suppliers

Italy, AFP Testing Market Diagnostics

Sales by Major Supplier

Italy, CEA Testing Market Diagnostics

Sales by Major Supplier

Italy, PSA Testing Market Diagnostics

Sales by Major Supplier


Europe Cell Surface Markers 2017-2021: France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

Complete report $3,850. DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year

USD 3850View Report

Europe Pap Smear/Papillomavirus (HPV) Diagnostics Market: France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

Complete report $2,850. DataPack (test volumes, sales forecasts) $1,850.This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance

USD 2850View Report

Europe Drugs of Abuse Testing Market 2017-2021: France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

This new 300-page report provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of

USD 6500View Report

Europe Cancer Diagnostics Market 2017-2021: France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review

Complete report $19,700.DataPack (test volumes, sales forecasts, supplier shares) $12,800.This comprehensive five-countryreport contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics

USD 19700View Report

Sienna Cancer Diagnostics Ltd Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Sienna Cancer Diagnostics Ltd Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT

USD 200View Report

MEDITE Cancer Diagnostics, Inc. Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

MEDITE Cancer Diagnostics, Inc. Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions,

USD 200View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF    $ 6700
  • Global Licence    $ 14700
  • DataPack    $ 4350
$ 6700

Reports Details

Published Date : Aug 2016
No. of Pages :570
Country :Italy
Category :Healthcare
Publisher :VPGMarketResearch.com
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment